These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25022105)

  • 1. [Symptomatic coronary heart disease. Therapy with a beta blocker and ivabradine combination].
    MMW Fortschr Med; 2014 Jun; 156(11):58-9. PubMed ID: 25022105
    [No Abstract]   [Full Text] [Related]  

  • 2. Ivabradine in combination with a beta-blocker. Stable angina: do not use instead, of or, with a beta-blocker.
    Prescrire Int; 2010 Dec; 19(111):279. PubMed ID: 21370517
    [No Abstract]   [Full Text] [Related]  

  • 3. [Symptomatic coronary heart diseases. Combination therapy is successful in general practice].
    MMW Fortschr Med; 2014 Nov; 156(20):75. PubMed ID: 25543378
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
    Tardif JC; Ponikowski P; Kahan T;
    Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivabradine: new drug. Best avoided in stable angina.
    Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heart rate reduction as a therapeutic strategy: novel options].
    Hoppe UC
    Internist (Berl); 2006 Dec; 47(12):1289-93. PubMed ID: 17077980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attaining therapy relevant goals with ivabradin].
    Lohmann M
    MMW Fortschr Med; 2014 Oct; 156(17):71. PubMed ID: 25417482
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
    J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relieve your patients of angina pectoris symptoms].
    Lohmann M
    MMW Fortschr Med; 2015 Aug; 157(14):76. PubMed ID: 26289894
    [No Abstract]   [Full Text] [Related]  

  • 10. Angina: Ivabradine for treatment of stable angina pectoris.
    de Silva R; Fox KM
    Nat Rev Cardiol; 2009 May; 6(5):329-30. PubMed ID: 19377492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac function during adrenergic beta receptor blockade in different types of angina pectoris and local reversible myocardial ischemia of varying duration (clinico-experimental studies)].
    Ol'binskaia LI; Bragina GI; Litvitskiĭ PF
    Ter Arkh; 1980; 52(5):50-4. PubMed ID: 6105728
    [No Abstract]   [Full Text] [Related]  

  • 12. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers or beta receptor antagonists for patients with ischaemic heart disease. What is the best choice?
    Rydén L; Malmberg K
    Eur Heart J; 1996 Jan; 17(1):1-3. PubMed ID: 8682115
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical results of I(f) current inhibition by ivabradine.
    Tardif JC
    Drugs; 2007; 67 Suppl 2():35-41. PubMed ID: 17999562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers in hypertensive and coronary heart disease.
    Goldstein S
    Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative efficacy of ivabradine and atenolol in correction of clinical and functional parameters in patients with stable effort angina].
    Tatarchenko IP; Pozdniakova NV; Biriuchenko MV
    Kardiologiia; 2008; 48(5):60-1. PubMed ID: 18537806
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivabradine for chronic heart failure?
    Drug Ther Bull; 2012 Oct; 50(10):117-20. PubMed ID: 23065752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable angina: role of ivabradine unchanged between 2006 and 2010.
    Massé JF
    Prescrire Int; 2010 Nov; 19(110):264; author reply 264-5. PubMed ID: 21284363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.